Testing effectiveness (Phase 2)Study completedNCT01816490What this trial is testingTHISTLE - The HIV-HCV Silibinin TrialWho this might be right forHIVHepatitis C University of Zurich 20
Not applicableNot Yet RecruitingNCT05752318What this trial is testingAnalysis of the Persistence, Reservoir and HIV LatencyWho this might be right forHIV Infected IndividualsInformed Consent University Hospital, Strasbourg, France 500
Post-approval studies (Phase 4)Study completedNCT00192660What this trial is testingHIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)Who this might be right forHIV-Associated Lipodystrophy SyndromeCardiovascular Disease Kirby Institute 80
Large-scale testing (Phase 3)Study completedNCT00001082What this trial is testingThe Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected PatientsWho this might be right forCytomegalovirus InfectionsHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 505
Not applicableStudy completedNCT00373048What this trial is testingMefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled TrialWho this might be right forHIV Infections Institute of Tropical Medicine, Belgium 300
Not applicableStudy completedNCT00001089What this trial is testingHIV and Cytomegalovirus (CMV) in HIV-Infected PatientsWho this might be right forCytomegalovirus InfectionsHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 400
Not applicableStudy completedNCT01381029What this trial is testingImmune Response to Seasonal Influenza Vaccine in HIV Infected IndividualsWho this might be right forInfluenza, HumanHuman Immunodeficiency Virus I Infection George Washington University 74
Not applicableWithdrawnNCT00023218What this trial is testingEffect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and FibrosisWho this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02511990What this trial is testingThe Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074Who this might be right forHealthyHIV Rockefeller University 33
Not applicableStudy completedNCT01985399What this trial is testingNeurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")Who this might be right forHIVAIDS Stanford University 100
Testing effectiveness (Phase 2)Study completedNCT00000838What this trial is testingAntiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 256
Not applicableStudy completedNCT00096824What this trial is testingDementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175Who this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 860
Large-scale testing (Phase 3)Study completedNCT00000736What this trial is testingSafety and Efficacy of Zidovudine for Asymptomatic HIV-Infected IndividualsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 3,200
Early research (Phase 1)Study completedNCT00052182What this trial is testingSafety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00520897What this trial is testingIntegrase Inhibitor (MK-0518) Viral DecayWho this might be right forHIV Infections Canadian Immunodeficiency Research Collaborative 24
Post-approval studies (Phase 4)Ended earlyNCT01245101What this trial is testingAddition of Raltegravir to Established Antiretroviral Suppressive TherapyWho this might be right forHIV University of Miami 15
Early research (Phase 1)Study completedNCT00000977What this trial is testingActive Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 52
Large-scale testing (Phase 3)Study completedNCT03178084What this trial is testingEffects of Maraviroc vs. Efavirenz on CD4/CD8 RatioWho this might be right forHIV/AIDS Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 721
Early research (Phase 1)Study completedNCT03570918What this trial is testingMGD014 in HIV-Infected Individuals on Suppressive Antiretroviral TherapyWho this might be right forHIV-1-infection MacroGenics 21
Testing effectiveness (Phase 2)Study completedNCT01714414What this trial is testingA Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy RegimenWho this might be right forHIV-1 Infection Michael Hoelscher 120